Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Corcept (CORT) Looks Good: Stock Moves Up 8.8% in Session
Corcept Therapeutics Incorporated (CORT - Free Report) was a big mover last session, as its shares rose over 8% on the day. The move came after the company delivered robust second-quarter 2017 results. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.90 to $12.97 in the past one-month time frame.
The company has seen one negative estimate revisions in the past 30 days while the Zacks Consensus Estimate hasn’t been in a trend /remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Corcept currently carries a Zacks Rank #3 (Hold).
Corcept Therapeutics Incorporated Price
Corcept Therapeutics Incorporated Price | Corcept Therapeutics Incorporated Quote
A better-ranked stock worth considering in the Medical - Drugs space is Nivalis Therapeutics, Inc. (ALPN - Free Report) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CORT going up? Or down? Predict to see what others think: Up or Down
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential.
See these stocks now>>